This is unlikely since: tizanidine’s alpha-2 agonist effects do not affect stroke [17]; and our negative control analysis of ICS + tizanidine was inconsistent with a large positive association (upper 95% confidence limit: 1.49). This evidence concerns the gene PSMA2 and stroke disorder.